Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2022-09-23 Regulatory Filings
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2022-09-23 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2022-09-23 English
Articles of Association
Governance Information Classification · 95% confidence The document is titled 'Articles of Association' for Pharmaron Beijing Co., Ltd. It contains detailed chapters on company governance, share issuance, shareholder meetings, board of directors, senior management, financial and accounting systems, and other corporate governance matters. The document is a comprehensive legal and governance framework for the company, approved at an extraordinary general meeting. It is not a financial report, earnings release, or announcement of voting results. It is a governance document detailing internal rules and structure of the company. Therefore, it fits the category of Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text, not just an announcement or summary.
2022-09-23 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS OF THE SECOND SESSION OF THE BOARD
Board/Management Information Classification · 95% confidence The document lists the members of the board of directors and their roles and functions, including details about board committees and their composition. It is focused on governance structure and board information rather than financial results, audit opinions, or shareholder voting outcomes. There is no indication of financial data, voting results, or report publication. The content aligns with announcements or disclosures about board composition and management structure, which fits the category of Board/Management Information (MANG). The document length is short and does not contain financial statements or detailed management discussion, so it is not an Annual Report or Management Report. Therefore, the appropriate classification is MANG with high confidence.
2022-09-23 English
(I) POLL RESULTS OF THE SECOND EXTRAORDINARY GENERAL MEETING OF 2022&#x3b; (II) CESSATION OF OFFICE OF INDEPENDENT NON-EXECUTIVE DIRECTORS&#x3b; (III) APPOINTMENTS OF INDEPENDENT NON-EXECUTIVE DIRECTO
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement from Pharmaron Beijing Co., Ltd. regarding the poll results of the Second Extraordinary General Meeting (EGM) of 2022. It details the voting outcomes on resolutions including the increase in registered capital, amendments to the Articles of Association, and appointments and cessations of independent non-executive directors. The document also includes information about the EGM's legal compliance, attendance, and voting procedures. There is no detailed financial data or comprehensive report content; rather, it is a formal announcement of shareholder voting results and related corporate governance changes. This fits the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is over 10,000 characters, indicating it is not a brief notice but a full announcement of voting results. Therefore, the appropriate classification is DVA with high confidence.
2022-09-23 English
Notification Letter and Request Form to Non-registered Holders - Notice of Publication of Circular and Notice of The Second Extraordinary General Meeting of 2022
Report Publication Announcement Classification · 100% confidence The document is a notification letter from Pharmaron Beijing Co., Ltd. dated 7 September 2022, informing non-registered shareholders about the publication of a circular and notice of the Second Extraordinary General Meeting of 2022. It provides instructions on how to access the circular and meeting notice on the company's and HKEX's websites and how to request printed versions of corporate communications. The document explicitly states it is a "Notice of Publication" and does not contain the actual circular or meeting notice itself. It also includes a request form for shareholders to receive future corporate communications. The document length is 6807 characters, which is relatively short and consistent with an announcement rather than a full report or circular. According to the "Menu vs Meal" rule, this is an announcement about the availability of a report (circular and meeting notice), not the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2022-09-07 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.